The Alderley Park Lighthouse Lab is hosted by Medicines Discovery Catapult at Bruntwood SciTech’s Alderley Park in Cheshire and officially began testing in April.
Professor Sir John Bell GBE FRS, UK Life Sciences Champion, said:
“The Alderley Park Lighthouse has been crucial for our testing program. With it operating at this level we have a testing program that will help with any second wave. Their performance has been exemplary.”
Lord Bethell, Minister for Testing, said:
“Alderley Park is showcasing the finest diagnostic science available to achieve the mass-throughput, fast-process COVID analysis, helping to save lives and protect the NHS. We are enormously grateful for the hard work of the team.”
Sir Jeremy Farrar, Director of the Wellcome Trust, said:
“The speed at which the Alderley Park Lighthouse programme has been set up to operate at this scale is nothing short of remarkable. A huge credit to everyone involved. The ability to accurately process thousands of tests a day, now over one million in total, is crucial to reduce the impact of this devastating pandemic as part of a successful test-trace-isolate strategy.”
PACE (Pathways to Antimicrobial Clinical Efficacy) and the UK Health Security Agency (UKHSA) have released five new contemporary antimicrobial resistance (AMR) strain panels, giving innovators worldwide a resource to test novel therapeutics and diagnostics against today’s resistance patterns.
New appointments support MDC’s mission to turn drug discovery into commercial breakthroughs.
